Evidence map›Paper›PMID 27173013›Full record

ArticleScientific reports2016

Enhancement of tendon-to-bone healing after anterior cruciate ligament reconstruction using bone marrow-derived mesenchymal stem cells genetically modified with bFGF/BMP2.

Biao Chen, Bin Li, Yong-Jian Qi, Qu-Bo Ni, Zheng-Qi Pan, Hui Wang, Liao-Bin Chen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Strategies for promoting tendon-bone healing: Current status and prospects.Frontiers in bioengineering and biotechnology · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Graft healing after anterior cruciate ligament reconstruction (ACLR).Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Biao ChenDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Bin LiDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Yong-Jian QiDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Qu-Bo NiDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Zheng-Qi PanDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Hui WangDepartment of Pharmacology, Basic Medical School, Wuhan University, Wuhan, China.
Liao-Bin ChenDepartment of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, China.
Zhongnan Hospital of Wuhan University · CNWuhan University · CNHubei Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many strategies, including various growth factors and gene transfer, have been used to augment healing after anterior cruciate ligament (ACL) reconstruction. The biological environment regulated by the growth factors during the stage of tendon-bone healing was considered important in controlling the integrating process. The purpose of this study was to evaluate the effects of bone marrow-derived mesenchymal stem cells (BMSCs) genetically modified with bone morphogenetic protein 2 (BMP2) and basic fibroblast growth factor (bFGF) on healing after ACL reconstruction. BMSCs were infected with an adenoviral vector encoding BMP2 (AdBMP2) or bFGF (AdbFGF). Then, the infected BMSCs were surgically implanted into the tendon-bone interface. At 12 weeks postoperatively, the formation of abundant cartilage-like cells, smaller tibial bone tunnel and significantly higher ultimate load and stiffness levels, through histological analysis, micro-computed tomography and biomechanical testing, were observed. In addition, the AdBMP2-plus-AdbFGF group had the smallest bone tunnel and the best mechanical properties among all the groups. The addition of BMP2 or bFGF by gene transfer resulted in better cellularity, new bone formation and higher mechanical property, which contributed to the healing process after ACL reconstruction. Furthermore, the co-application of these two genes was more powerful and efficient than either single gene therapy.

Indexed as

Wound HealingAnimalsAnterior Cruciate Ligament ReconstructionBone Morphogenetic Protein 2Cells, CulturedCell SurvivalCombined Modality TherapyDependovirusDisease Models, AnimalFibroblast Growth Factor 2Genetic TherapyGenetic VectorsHumansMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationBMP2 protein, humanBone Morphogenetic Protein 2Fibroblast Growth Factor 2

Identifiers

PMID27173013
PMCPMC4865959
OpenAlexW2381411745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.